Investors

Investors

Investors

Featured

Novartis Quarterly Financial Results

Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news...
Read More

Share Price

CHF as of Sep 30, 17:31 CEST
USD as of Sep 30, 16:02 EDT
View stock performance

Media Release / Sep 28
Novartis announces Phase III study shows AMG 334 significantly reduces monthly migraine days in people with episodic migraine

Read More

Media Release / Sep 28
Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges

Read More

In this section

Event Calendar
Find out about upcoming Novartis Investor Relations events.
Company Overview
Learn about Novartis leaders, corporate governance, our clinical pipeline and more.
Share Data & Analysis
Access information on Novartis share performance and dividend payouts.
Financial Data
Review and download annual and quarterly reports, SEC filings and product sales information.
Shareholder Information
Find information for shareholders and answers to frequently asked questions.
Investor Contact
For questions about Investor Relations or the share registry, please contact our team.

Quick Links

News
Novartis Annual Report 2015
Shareholder Information
Annual General Meeting
Investors
Novartis Fact Sheet
Shareholder Information
For Japanese Investors
Corporate Responsibility

We apply our expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of our business strategy.

Read More